Tag: anti-TNF

Mixed results for Pfizer’s Xeljanz in RA trial

by Selina McKee | Feb 17, 2017 | News | 0

Pfizer has reported mixed data from a late-stage trial pitting the efficacy of its JAK inhibitor Xeljanz against AbbVie’s super blockbuster Humira, the world’s top-selling drug, in patients with rheumatoid arthritis.

EU nod for Samsung Bioepis’ Remicade biosimilar

by Selina McKee | May 31, 2016 | News | 0

Samsung Bioepis’ biosimilar of Johnson & Johnson’s blockbuster anti-inflammatory infliximab has won regulatory approval in Europe, potentially further expanding access to anti-TNF therapies in the region.